Journal
BMC MEDICINE
Volume 15, Issue -, Pages -Publisher
BMC
DOI: 10.1186/s12916-017-0784-x
Keywords
AMY1A/AMY2A; Body mass index; Copy number variant; Mendelian randomization; Metabonomics; Obesity; Salivary/Pancreatic amylase; Starch
Categories
Funding
- French National Research Agency [ANR-10-LABX-46, ANR-10-EQPX-07-01]
- European Research Council (ERC GEPIDIAB) [294785]
- FEDER
- Qatar Foundation
- Region Nord Pas-de-Calais
- Inserm
- CNAMTS
- Lilly
- Novartis Pharma
- Sanofi-Aventis
- Association Diabete Risque Vasculaire
- Federation Francaise de Cardiologie
- La Fondation de France
- Societe Francophone du Diabete
- ONIVINS
- Ardix Medical
- Bayer Diagnostics
- Becton Dickinson
- Cardionics
- Merck Sante
- Novo Nordisk
- Pierre Fabre
- Roche
- Topcon
- European Research Council (ERC) [294785] Funding Source: European Research Council (ERC)
Ask authors/readers for more resources
Background: Salivary (AMY1) and pancreatic (AMY2) amylases hydrolyze starch. Copy number of AMY1A (encoding AMY1) was reported to be higher in populations with a high-starch diet and reduced in obese people. These results based on quantitative PCR have been challenged recently. We aimed to re-assess the relationship between amylase and adiposity using a systems biology approach. Methods: We assessed the association between plasma enzymatic activity of AMY1 or AMY2, and several metabolic traits in almost 4000 French individuals from D. E. S. I. R. longitudinal study. The effect of the number of copies of AMY1A (encoding AMY1) or AMY2A (encoding AMY2) measured through droplet digital PCR was then analyzed on the same parameters in the same study. A Mendelian randomization analysis was also performed. We subsequently assessed the association between AMY1A copy number and obesity risk in two case-control studies (5000 samples in total). Finally, we assessed the association between body mass index (BMI)-related plasma metabolites and AMY1 or AMY2 activity. Results: We evidenced strong associations between AMY1 or AMY2 activity and lower BMI. However, we found a modest contribution of AMY1A copy number to lower BMI. Mendelian randomization identified a causal negative effect of BMI on AMY1 and AMY2 activities. Yet, we also found a significant negative contribution of AMY1 activity at baseline to the change in BMI during the 9-year follow-up, and a significant contribution of AMY1A copy number to lower obesity risk in children, suggesting a bidirectional relationship between AMY1 activity and adiposity. Metabonomics identified a BMI-independent association between AMY1 activity and lactate, a product of complex carbohydrate fermentation. Conclusions: These findings provide new insights into the involvement of amylase in adiposity and starch metabolism.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available